Proteome Sciences (PRM.L) Stock Price
£4.06 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Proteome Sciences, AI stock picks, stock alerts and much more.
PRM.L AI Stock Analysis
AI stock analysis for PRM.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Proteome Sciences (PRM.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Proteome Sciences (PRM.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Proteome Sciences (PRM.L), currently trading at £4.06, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PRM.L
-
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union.
-
Symbol
PRM.L
-
Market
LSE
-
Industry
Medical - Diagnostics & Research
-
Market Cap
12M
Similar Stocks
 |
Lonza Group AG 0QNO.L |
CHF566.2 0.4% |
5 |
 |
LungLife AI LLAI.L |
£1.1 12% |
4 |
 |
ANGLE AGL.L |
£9 7.7% |
3 |
 |
Diaceutics PLC DXRX.L |
£125 0.00% |
5 |
 |
genedrive GDR.L |
£1.8 1.4% |
2 |
News
PRM.L Alternative Data
Web Traffic
Proteome Sciences receives an estimated 2537 monthly visitors to proteomics.com.
-
Web Traffic
2537
-
Change from Previous Month
81.2%
-
3 Month Change
7.5%
-
YoY Change
7.5%
News Mentions
Proteome Sciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
50%
-
3 Month Change
0%
Twitter Followers
Proteome Sciences has 434 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
434
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
1.6%
Job Postings
Proteome Sciences currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Proteome Sciences has 32 employees.
-
LinkedIn Employees
32
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3%
Reddit Mentions
Proteome Sciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
PRM.L Financials
PRM.L Key Metrics
-
Total Revenue
£2.2M
-
Net Income
-£2.2M
-
Earnings per Share
-£0.0075
-
Free cash flow
-£523K
-
EBITDA
-£1.3M
-
EBITDA Ratio
-0.575553
-
Total Assets
£9.5M
PRM.L 2-year Revenue & Income
PRM.L 2-year Free Cash Flow
PRM.L Technicals
PRM.L SMA
PRM.L RSI
FAQ
What's the current price of Proteome Sciences (PRM.L) Stock?
The price of an Proteome Sciences (PRM.L) share is £4.06.
What's the market cap of Proteome Sciences?
The current market cap of Proteome Sciences is 12M.
Should I buy or sell PRM.L?
Proteome Sciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Proteome Sciences is better viewed as a hold or accumulate position while waiting for further developments.
Is Proteome Sciences a good investment?
The current analysis of Proteome Sciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Proteome Sciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Proteome Sciences (PRM.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Proteome Sciences stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Proteome Sciences (PRM.L) that investors often compare it to?
Proteome Sciences (PRM.L) is often compared to similar stocks such as Lonza Group AG, LungLife AI, ANGLE, Diaceutics PLC and genedrive.
What is the forecast for Proteome Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Proteome Sciences' stock price to be around £4.15 in 2026. Starting from the current price of £4.06, this represents a 2.2% change in price, indicating a neutral outlook for the stock.
How to buy Proteome Sciences (PRM.L) Stock?
Proteome Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Proteome Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.